August 6, 2025International Journal of Molecular SciencesOpen Access

A Narrative Review of Theranostics in Neuro-Oncology: Advancing Brain Tumor Diagnosis and Treatment Through Nuclear Medicine and Artificial Intelligence

View Full Paper

Ask AI

Bookmark

Authors

RCRafail C. ChristodoulouStanford University PPPlaton S. PapageorgiouNational and Kapodistrian University of Athens RPRafael PitsillosCyprus Institute of Neurology and Genetics

Discussion

Member takes

Implication

Narrative review shows advancements in theranostics and artificial intelligence for brain tumor diagnostics, suggesting a new direction in neuro-oncology.

Key Points

MAIN FINDING: Integration of AI and theranostics can significantly advance brain tumor diagnostics and treatments.
KEY EVIDENCE: Novel theranostic agents, including Lu-177 radiopharmaceuticals, enhance tumor targeting and monitoring.
APPROACH: Literature was reviewed from articles published between 2020 and mid-2025, covering both clinical and preclinical studies.
SIGNIFICANCE: AI's application in imaging analysis and predictive modeling may revolutionize personalized medicine in neuro-oncology.

Cite This Study

Christodoulou et al. (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d15d3 https://doi.org/10.3390/ijms26157396

View Full Paper

Ask AI

Bookmark

Implication

Narrative review shows advancements in theranostics and artificial intelligence for brain tumor diagnostics, suggesting a new direction in neuro-oncology.

A Narrative Review of Theranostics in Neuro-Oncology: Advancing Brain Tumor Diagnosis and Treatment Through Nuclear Medicine and Artificial Intelligence

Discussion

Member takes

Implication

Key Points

Cite This Study

A Narrative Review of Theranostics in Neuro-Oncology: Advancing Brain Tumor Diagnosis and Treatment Through Nuclear Medicine and Artificial Intelligence

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider